NCT06642714

Brief Summary

The aim of our study was to assess the feasibility of an early NIV and progressive HFOT through tracheostomy tube weaning protocol implemented by tracheostomized patients with PMV referred to a specialized weaning unit of a rehabilitation hospital.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

6.6 years

First QC Date

October 9, 2024

Last Update Submit

October 11, 2024

Conditions

Keywords

tracheostomymechanical ventilationnon-invasive ventilationHigh flow oxygen therapy

Outcome Measures

Primary Outcomes (1)

  • weaning success

    through study completion, an average of 100 days

Secondary Outcomes (9)

  • mechanical ventilation days

    120 days

  • weaning duration

    through study completion, an average of 120 days

  • Length of stay

    6 months

  • 1 year survival

    1 year

  • Rate of extubation

    through study completion, an average of 100 days

  • +4 more secondary outcomes

Study Arms (1)

weaning group

OTHER

Patients included in the study will not be randomized individually but will be managed either according to the standard of care of the service or according to the personalized strategy (according to the stepped wedge group of the center).

Procedure: weaning by early non-invasive ventilation and progressive high flow oxygen therapy

Interventions

Step 1 Clinical stability was confirmed: (1)Without organ failure;(2)Without sepsis;(3)Stable heart rate and blood pressure without use of vascular active drugs. Step2 Reduce the support parameters of the ventilator gradually. Step3 SBT when the ventilator mode is pressure support ventilation(PSV),P+PEEP≤16cmH2O for 2 hours. Step4 ①Success of SBT: titrate based HFOT time-------connected with tracheostomy tube ,flow rate and FiO2 able to maintain oxygen saturation as assessed by pulse oximetry monitoring of at least 95%.HFOT was interrupted in cases of sighs or symptoms of distress such as oxygen desaturation, RR\>30bpm, HR\>130bpm,SBP\>180mmHg or \<90mmHg.The time was based HFOT time. When any of these conditions were present the patient was connected again to the ventilator with the same parameters before titration. The duration of SBT was increased progressively over the following day according to patient tolerance. Then gradually extending HFOT time daily according patient condition. Wh

weaning group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years old;
  • After tracheotomy;
  • Patients who met the definition of long-term mechanical ventilation (requiring invasive mechanical ventilation for more than 6 hours per day for more than 21 consecutive days);
  • willing to participate in this study and signed the informed consent.

You may not qualify if:

  • The expected survival time less than 3 months;
  • Participated in another clinical study related to weaning;
  • death or discharge within 2 weeks after referral;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Rehabilitation Hospital of Capital Medical University

Beijing, China

Location

Study Officials

  • Jingyi Ge

    Study Principal Investigator

    PRINCIPAL INVESTIGATOR
  • Jingyi Ge

    Beijing Rehabilitation Hospital of Capital Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

February 1, 2018

Primary Completion

September 3, 2024

Study Completion

October 30, 2024

Last Updated

October 15, 2024

Record last verified: 2024-10

Locations